| NCT ID | NCT05653141 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Roza Umarova |
| Condition | First-ever Ischemic Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2020-12-17 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2020-12-17 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Present study aims to track the post-stroke cognitive trajectories and to investigate its inter-individual variability.
Eligibility Criteria
Inclusion Criteria: * Age ≥18 years old * First-ever anterior circulation ischemic stroke confirmed by routine MRI * Time of enrollment: ≤ 10 days from stroke onset. Exclusion Criteria: * Previous stroke anamnestic or based on clinical imaging * Additional stroke in posterior circulation * Conditions that preclude the cognitive testing (e.g. delirium, intubation, reduced vigilance * Neurological or psychiatric conditions that preclude the data interpretation (e.g. pre-stroke dementia, schizophrenia, brain tumor, regular intake of benzodiazepine, depression) * MRI contraindication * Native language other than German, French or Italian
Contact & Investigator
Roza M. Umarova, PD Dr.
PRINCIPAL INVESTIGATOR
Department of Neurology, Inselspital, University Hospital Bern, University of Bern
Frequently Asked Questions
Who can join the NCT05653141 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying First-ever Ischemic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05653141 currently recruiting?
Yes, NCT05653141 is actively recruiting participants. Contact the research team at roza.umarova@insel.ch for enrollment information.
Where is the NCT05653141 trial being conducted?
This trial is being conducted at Bern, Switzerland.
Who is sponsoring the NCT05653141 clinical trial?
NCT05653141 is sponsored by Roza Umarova. The principal investigator is Roza M. Umarova, PD Dr. at Department of Neurology, Inselspital, University Hospital Bern, University of Bern. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.